Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $245.86. The company's market cap stands at 592.5B, with a P/E ratio of 22.28 and a dividend yield of 2.1%.
On 2026-02-25, Johnson & Johnson(JNJ) stock traded between a low of $244.43 and a high of $245.90. Shares are currently priced at $245.86, which is +0.6% above the low and -0.0% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 635.3K, against a daily average of 9.59M.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $247.25 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $247.25 at its peak.
JNJ News
Recently, a Philadelphia jury found Johnson & Johnson liable in a talc ovarian cancer case, awarding US$250,000 in compensatory and punitive damages over allege...
Johnson & Johnson announced the submission of a supplemental Biologics License Application to the U.S. FDA seeking approval of Imaavy as the first-ever treatmen...
Johnson & Johnson (JNJ) has packed several clinically focused announcements into February, including new subcutaneous dosing approvals for RYBREVANT, long term...
Analyst ratings
57%
of 28 ratingsMore JNJ News
(RTTNews) - German pharmaceutical and life sciences major Bayer AG (BAYRY.PK, BAYZF.PK) announced that it has filed false advertising suit against Johnson & Joh...
ORIC Pharmaceuticals (NasdaqGS:ORIC) reports progress in its cancer therapy pipeline, with lead drug candidates entering Phase 1b clinical trials. The company...
German drugmaker Bayer (BAYRY) for the second time this year came at Johnson & Johnson (JNJ) with a new lawsuit. However, the American health giant’s shares def...
Healthcare giant Johnson & Johnson’s (JNJ) shares failed to get off the ground in Monday’s pre-market trading. This is despite entering its first co-funding agr...
(RTTNews) - Blackstone Life Sciences, a division of Blackstone Inc. (BX), Monday announced a research and development funding agreement with Johnson & Johnson (...
Johnson & Johnson (NYSE:JNJ) is preparing a potential sale of its DePuy Synthes orthopedics unit that could exceed $20b. The company has also dropped formal di...
Key Points Johnson & Johnson is a core player in global healthcare. A diverse portfolio, fortress-like balance sheet, and industry tailwinds cement a growing...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.